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Aims The epidermal growth factor-like protein Delta-like 1 (DLK1) regulates multiple differentiation processes. It resem-
bles NOTCH ligands structurally and is considered a non-canonical ligand. Given the crucial role of the NOTCH
pathway in angiogenesis, we hypothesized that DLK1 could regulate angiogenesis by interfering with NOTCH.
We therefore investigated the expression and function of DLK1 in the vascular endothelium and its role in the regu-
lation of angiogenesis.
Methods
and results
We report DLK1 expression in the endothelium of different species, including human, cow, pig, and mouse. Angio-
genesis was studied by using in vitro and in vivo models of angiotube formation in endothelial cells, retinal phenotypes
in Dlk1-null mice, and vessel development in zebrafish. DLK1 overexpression strongly inhibited angiotube formation,
whereas lung endothelial cells from Dlk1-null mice were highly angiogenic. In vivo studies demonstrated DLK1-
mediated inhibition of neovessel formation and revealed an altered pattern of angiogenesis in the retinas of Dlk1-
null mice. The expression of human DLK1 in zebrafish embryos severely altered the formation of intersegmental
vessels, while knockdown of the orthologous gene was associated with ectopic and increased tumour-induced angio-
genesis. NOTCH-dependent signalling as determined by gene expression reporters was inhibited by the presence of
DLK1 in vascular endothelial cells. In contrast, Dlk1-null mice showed increased levels of NOTCH downstream
targets, such as Snail and Slug.
Conclusion Our results unveil a novel inhibitory role for DLK1 in the regulation of angiogenesis, mediated by antagonism of the
NOTCH pathway, and establish the basis for investigating its action in pathological settings.
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1. Introduction
Delta-like 1 (DLK1), also known as Pref-1 and FA1, is a transmem-
brane protein pertaining to the epidermal growth factor superfamily
and initially described in neuroendocrine tumours and
preadipocytes.1,2 It has been described that DLK1 affects several dif-
ferentiation processes, including adipogenesis, muscular and neuronal
differentiation, bone differentiation, and haematopoiesis.3 Several
reports from our groups and others support that DLK1 may
operate as a non-canonical ligand of the NOTCH pathway, as it
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lacks the DSL domain conserved in classic NOTCH ligands that med-
iates ligand–receptor interaction.4–6 This structural feature has been
related to its capacity to inhibit NOTCH signalling in different cellular
systems and organisms, by the interactions with specific EGF-like
repeats of NOTCH.7 The potentially diverse effects of DLK1 would
then depend on the cell context and state of NOTCH activation.8
To date, information on the presence of DLK1 in adult endothelia
is restricted to adipose tissue vascular cells and placental blood
vessels,9,10 and to our knowledge, there are no functional data in
the vasculature.
Angiogenesis, defined as the formation of new blood vessels from
pre-existing ones, is a central process in embryonic and post-natal life
and the object of intense study due to its relevance for tumour pro-
gression and therapy.11 Since the NOTCH signalling pathway is essen-
tial for vascular development and physiology by controlling
angiogenesis in pre- and post-natal life,12,13 we reasoned that DLK1
could contribute to regulate this process in adult endothelial cells
through the interaction with NOTCH receptors. In this study, we ana-
lysed the role of DLK1 in angiogenesis by using a series of in vitro and
in vivo approaches. We find that overexpression of DLK1 inhibits mi-
gration and angiotube formation in mammalian vascular endothelial
cells and disrupts normal embryonic vascularization in zebrafish.
Genetic ablation of DLK1 in mice is associated with increased angio-
genesis in vitro and with focal areas of retinal hypervascularization.
Specific knockdown of the orthologous Dlk1 of zebrafish results in
ectopic angiogenesis. Moreover, in a tumour angiogenesis model in
zebrafish, suppression of Dlk1 promotes vessel migration towards
the tumour cell mass. We also find that the NOTCH signalling
pathway is targeted by DLK1 in the context of angiogenesis and
that DLK1 antagonizes NOTCH-dependent signalling in endothelial
cells, while, in contrast, this signalling is enhanced in Dlk1-null mice.
Collectively, these results reveal a previously unknown role for
DLK1 in the vasculature as a regulator of NOTCH-mediated
angiogenesis.
2. Methods
2.1 Adenoviruses
Adenoviruses encoding GFP, DLK1-GFP, or DLK1-HA were obtained
from Vector Biolabs. Adenoviruses were purified using the Adeno-X
Maxi Purification Kit and titered using the Adeno-X Rapid Titer Kit
(Clontech).
2.2 Cell culture and animal handling
Bovine aortic endothelial cells (BAEC) and porcine aortic endothelial cells
(PAEC) were obtained from cow and pig aortas at a local slaughterhouse
and cultured as described.14 For isolation of mouse lung endothelial cells
(MLEC), mice were sacrificed by cervical dislocation and lungs were
excised and collagenase-digested. The mixed population obtained was
first subjected to negative selection with anti-FCsRII/III and then to posi-
tive selection with anti-ICAM-2 and anti-IgG-coated magnetic beads.
MLEC were grown on a mixture of fibronectin, type I collagen, and
0.1% gelatine-coated plates. Isolation of human umbilical vein endothelial
cells is described in Supplementary material online. They were obtained
from umbilical cords of normal deliveries (after approval by the Ethics
Committee of the Hospital ‘Ruber Internacional’) and in agreement
with principles outlined in the Declaration of Helsinki. Animals were
handled in agreement with the Guide for the Care and Use of Laboratory
Animals contained in Directive 2010/63/EU of the European Parliament.
Approval was granted by the local ethics review board of Centro de Bio-
logı´a Molecular ‘Severo Ochoa’.
2.3 Western blot analysis
Details are provided in Supplementary material online.
2.4 Cell proliferation assays
Endothelial cells were at a density of 3000 cells/well. XTT turnover was
measured at 0, 24, 48, 72, and 96 h after 4 h incubation at 378C to
allow colour development (Cell Proliferation Kit II). BrdU incorporation
at 4, 8, and 24 h was detected by anti-BrdU (1:100), followed by
anti-rat (1:200; Alexa 488). Images were taken with a Nikon eclipse
TE2000-U inverted-microscope coupled to a digital-sight DS-2Mv.
2.5 Cell transfection and luciferase assay
DLK1 plasmid was obtained from Origene (pCMV6 XL4, human cDNA
clone, SC127962). A haemagglutinin tag was added (Vector Biolabs).
The Hes-1 luciferase reporter construction, containing a 350 bp mouse
promoter fragment of the Hes-1 gene inserted upstream of the luciferase
gene in pGL2 Basic, has been reported elsewhere.15 Endothelial cell trans-
fection and determination of luciferase activity are detailed in Supplemen-
tary material online.
2.6 Scratch assay
Endothelial cell monolayers were mechanically wounded and the rate of
coverage of the denuded area was monitored by time-lapse microscopy
for 24 h as described,16 using a Leica AF6000 LX microscopy coupled
to a monochromatic Hamamatsu CCD C9100-02.
2.7 Tube-like structure formation in vitro
The microcapillary-like formation assay was performed by using 96-well
culture plates coated with 40 mL of Matrigel (BD Bioscience) as
described.17 Endothelial cells with or without vascular endothelial
growth factor (VEGF; 5 ng/mL) were seeded on the polymerized Matrigel
and incubated at 378C for 5–6 h. Angiotubes were stained with MTT.
Images were taken with a Nikon eclipse TE2000-U inverted microscope
coupled to a digital-sight DS-2Mv. Tube formation was quantified by
using the Angioquant software.
2.8 Aortic ring assay
Rings of mouse aorta were cultures in three-dimensional gels as
described.18 Thoracic aortas were removed from mice sacrificed by cer-
vical dislocation. Pieces of aortas were immediately exposed or not to re-
combinant adenoviruses at 1 × 109 or 5 × 109 plaque-forming units/mL.
Four hours after infection, 1 mm long rings were embedded in Growth
Factor Reduced Matrigel in 96-well plates. Each well contained 100 mL
of MCDB131 supplemented with 2.5% mouse serum, 1% glutamine, and
1% P/S. After 6 days of culture, explants were examined by microscopy.
The length of vessels was quantified by ImageJ.
2.9 Matrigel plug assay in vivo
Growth Factor Reduced Matrigel Phenol Red-free (500 mL), heparin
(0.3 mg/mL), and VEGF (250 ng/mL), adenovirus, DAPT (10 mg/kg of
body weight) or DMSO (0.01%), as appropriate, were injected subcutane-
ously in the mice abdominal region. Mice were anaesthetized by injecting
(ip) ketamine (100 mg/kg) plus xylazine (10 mg/kg) and constantly moni-
tored by veterinarian surveillance of reflex absence. Animals were eutha-
nized in a CO2 chamber after day 10 of implantation, plugs were
dissected, and haemoglobin was measured using the TMB method
(Sigma). Haemoglobin content was normalized to plug weight. In
another set of experiments, plugs were removed for histological examin-
ation. Formaldehyde-fixed plugs were embedded in paraffin-wax and
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sectioned followed by staining with haematoxylin and eosin and examin-
ation under a light microscope (Olympus DX50).
2.10 Retinal isolation and staining
P0-P14 pups were sacrificed in a CO2 chamber and eyes enucleated and
fixed overnight in 1% PFA at 48C. Then, retinas were dissected out and
whole-mount stained with biotinylated isolectin B4 (Sigma-Aldrich) fol-
lowed by streptavidin, Alexa Fluor 647 conjugate (Invitrogen) as
described.19 Images from 8 to 10 retinas per experimental group were
acquired in a Nikon A1R confocal microscope, and quantification of tip
cells, filopodia, and vascular areas was carried out with ImageJ software.
2.11 Zebrafish DLK1 gain- and loss-of-function
assays
Zebrafish (Danio rerio) were maintained and raised under standard condi-
tions at 288C. Transgenic Tg(fli1:EGFP) and Tg(gata1:dsRed) embryos were
used to track endothelial cell populations and blood flow. Tg(fli1:EGFP);
Tg(gata1:dsRed) were generated by standard crossing of individual lines.
A plasmid encoding the human DLK1 cDNA was injected at different con-
centrations in one-cell stage embryos. The same plasmid without the
human DLK1 cDNA was used as a control. Embryos were allowed to
develop and pictures were taken at 72 hpf using a dissection microscope
equipped with epifluorescence (MZF16FA, Leica) and a digital camera
(DFC310FX, Leica). Sequences and experiments regarding anti-sense
morpholinos (MO) are described in Supplementary material online.
2.12 Zebrafish tumour xenograft angiogenesis
assay
Tg(fli:eGFP)20 embryos were injected at one-cell stage with MO against
zfDLK1 or capped hDLK1 mRNA or both, and allowed to develop at
288C. Twenty-four hours post-fertilization fish embryos were incubated
with water containing 0.2 mM 1-phenyl-2-thio-urea (Sigma) to prevent
pigmentation. At 48 h post-fertilization, zebrafish embryos were dechor-
ionated with the help of a sharp tip forceps and anaesthetized with
tricaine (MS-222, Sigma). Anaesthetized embryos were transferred onto
a modified agarose gel for microinjection. Before injection, tumour
cells were labelled in vitro with 2 mg/mL of 1,1-dioctadecyl-3,3,3′,3′-
tetramethylindocarbocyanine perchlorate (DiI, Fluka) and were further
incubated for 24 h. Cells were resuspended in DMEM and 2–5 nL of
tumour cell solution (25 cells/nL) was injected into the perivitelline
cavity of each embryo using an Eppendorf microinjector (FemtoJet
5247). After injection, the fish embryos were immediately transferred
into housing-keeping water. Injected embryos were kept at 288C and
were examined 2 days after to monitor tumour-induced angiogenesis
from subintestinal vessels (SIV) using a fluorescent microscope
(MZF16FA, Leica) equipped with a digital camera (MZF16FA, Leica).
2.13 Zebrafish NOTCH-reporter assay
Tg(ptf1a:eGFP)jh1 is a transgenic NOTCH-responsive zebrafish line har-
bouring 12 Rbp-Jk-binding sites up-stream of the b-globin minimal pro-
moter and the enhanced Green fluorescent protein reporter gene.21
Tg(ptf1a:eGFP)jh1 embryos were injected at one-cell stage with MO
against zfDLK1 or capped hDLK1 mRNA or were treated at 36 hpf
with DAPT for 12 h and allowed to develop at 288C. Details of the proto-
col are described in Supplementary material online.
2.14 RNA extraction and real-time PCR
Detailed methods and primers used are described in Supplementary ma-
terial online, Table S1.
2.15 Statistical analysis
Comparisons were evaluated by Student’s t-test for unpaired data or
one-way analysis of variance when parametric tests were possible or by
non-parametric tests, as appropriate.
3. Results
3.1 DLK1 is expressed in endothelial cells
where its presence correlates inversely with
angiotube formation and delays wound
healing
Given the scarce information on DLK1 in the vasculature, we first
studied its expression in several endothelial cell types and species.
We found that DLK1 was expressed in murine, human, porcine,
and bovine adult endothelial cells (Figure 1A). In the description of
the phenotype corresponding to the Dlk1-null mice, obesity and
serious osteo-skeletal malformations were reported22 but no explicit
allusion was made to any changes in the vasculature. For this reason,
we undertook studies in MLEC derived from Dlk1-null mice23 and
observed increased formation of angiotubes both in the absence
and presence of VEGF (Figure 1B). This phenotype was reversed
by the introduction of adenoviral expression constructs bearing
DLK1 (Figure 1C). In addition, BAEC overexpressing DLK1 showed
delayed re-endothelization after 18 h of in-plate endothelial wound-
ing (scratch assay) (see Supplementary material online, Figure S1A).
Consistently, wound closure was significantly accelerated in MLEC
from DLK1-null mice (see Supplementary material online, Figure
S1B and C; see Supplementary material online, Videos S1 and S2).
To address the contribution of proliferation and/or apoptosis to
the final effect observed, we evaluated the consequences of DLK1
suppression in MLEC. We found that the absence of DLK1 signifi-
cantly correlated with increased cell proliferation (see Supplemen-
tary material online, Figure S1D and E). However, DLK1 did not
interfere with apoptosis or necrosis (see Supplementary material
online, Figure S2). These results suggest a dual inhibitory effect of
DLK1 on the migration and proliferation of these endothelial cell
types.
3.2 The absence of DLK1 is associated with
increased sprouting angiogenesis while
DLK1 overexpression inhibits neovessel
formation in vivo
To examine the effect of DLK1 on angiogenesis in an ex vivo model,
we studied the outgrowth of endothelial cells from aortic explants
obtained from WT or Dlk1-null mice. Aortic segments from null
mice exhibited a significantly higher pro-angiogenic profile
(Figure 2A) that was abrogated in a dose-dependent fashion when
DLK1 was expressed in aorta explants of the null mutant background
(Figure 2B). We then investigated the effect of DLK1 expression con-
structs in an in vivo model of ectopic angiogenesis based on the forma-
tion of vessels in Matrigelw plugs implanted subcutaneously in the
abdominal region of healthy mice. Whereas VEGF-treated plugs
showed macroscopic neovessel formation and increased haemoglobin
content, functional vascular structures were drastically reduced in
plugs exposed to DLK1 expression constructs compared with con-
trols, an effect comparable in magnitude to that observed in plugs
P. Rodrı´guez et al.234
by guest on June 8, 2016
D
ow
nloaded from
 
Figure 1 Expression of DLK1 in adult endothelia and reciprocal relationship between DLK1 and angiogenesis. (A) Left blot showing DLK1 dimer in
non-boiled lysates (30 mg) of endothelial cells from mouse (MLEC), human (HUVEC), pig (PAEC), and cow (BAEC) as well as 3T3 cells (1 mg) by a
specific antibody. b-Actin was used as a loading control. Right blot showing non-boiled lysates from MLEC WT and KO. Samples were assayed from
two independent preparations. (B) Representative images from wild-type and DLK1-null isolated MLEC in the presence or absence of VEGF. Quan-
titative analysis represents the number of tube-like structures from three independent preparations per group. Values are presented as mean+ SEM
assayed per duplicate (*P, 0.05). (C ) Cells from DLK1 null were infected with adenoviruses GFP or DLK1-GFP. (D) Lysates (45 mg) from cells
infected with adenoviruses GFP or DLK1-GFP were incubated with DLK1, GFP, and actin antibodies. Representative image of endothelial cells
24 h after infection at a multiplicity of infection of 500 showing an infection efficiency of 90%. Scale bars: B: 500; C: 100 and D: 50 mm.
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Figure 2 DLK1 regulates angiogenesis in vivo. (A) Representative images from wild-type and DLK1-null aorta segments. The quantification of vessel-
like structures length (lower panel) shows an increase in neovessel outgrowth from explants of null mice. Values are presented as mean+ SEM of
n ¼ 35 rings from six mice; *P, 0.05. (B) The pro-angiogenic response of the null mice is abolished in explants pre-incubated with a DLK1 adenovirus
in a concentration-dependent manner, 1 × 109 (middle panel) and 5 × 109 (lower panel) plaque-forming units/mL compared with GFP adenovirus
(upper panel). (C) Ectopic angiogenesis was analysed in Matrigel plugs containing adenovirus (1 × 109 plaque-forming units/mL) control, or plugs con-
taining VEGF plus adenovirus control, Ad.DLK1, Ad.DLK1-GFP, DAPT, or vehicle (DMSO). Photograph of plugs after 10 days of implantation. The
quantification of haemoglobin content (right panel) shows that the VEGF pro-angiogenic effect is reduced in plugs containing DLK1 or DAPT. Values
represent mean+ SEM from six mice (*P, 0.05 vs. Ad.GFP plus VEGF). (D) Haematoxylin- and eosin-stained sections of the plugs show decreased
vascularization in Ad.DLK1, Ad.DLK1-GFP, and DAPT-treated plugs. Scale bars: A: 1 mm; B: 100 mm; D: 50 mm.
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treated with the g-secretase inhibitor DAPT which is a established in-
hibitor of the NOTCH pathway24 (Figure 2C and D).
3.3 The absence of DLK1 correlates with
focal retinal hyperangiogenesis
To confirm the antiangiogenic role of DLK1 in vivo, we studied the po-
tential differences in retinal vessel formation in Dlk1-null mice com-
pared with their wild-type counterparts. Retinas from null mice
showed focal hypervascularization at p5 and p14 (Figure 3A; see Sup-
plementary material online, Figure S3). This hypervascularization was
enhanced at p5, indicating a more prominent role of DLK1 in the
regulation of vascular leading edge progression (p5) than in remodel-
ling (p14). In the developing murine retina, sprouting angiogenesis
correlates well with the formation of endothelial tip cells and filo-
podia.12 A detailed study of the affected regions in the retinas of
Dlk1-null mice demonstrated an increased number of filopodia and
tip cells (Figure 3B), consistent with a dysregulation of angiogenesis.
Collectively, our results indicate that DLK1 acts as a brake for
proliferation, migration, and angiogenesis in the vascular endothelium
of post-natal mammals.
3.4 DLK1 regulates vascular development
and tumour angiogenesis in zebrafish
To investigate whether the role of DLK1 in angiogenesis could be
extended to other vertebrate models, we performed experiments
in embryos from Danio Rerio (zebrafish), in which the human
version of DLK1 was microinjected and overexpressed in one-cell
stage embryo. Three days after the injection, embryos expressing
DLK1 showed an abnormal pattern of dorsal vascularization that
was DLK1 dose-dependent, manifested in aberrant intersegmental
vessel branching and a lack of an established dorsal longitudinal anas-
tomotic vessel (Figure 4A–F; see Supplementary material online, Figure
S4). To decipher whether DLK1 played a role by itself in the develop-
ment of zebrafish vasculature, the endogenous orthologous mRNA
was targeted with an MO. Upon MO injection, 6 days old larvae
showed ectopic subintestinal angiogenesis (Figure 4G–J). This pheno-
type was MO dose-dependent and was rescued by the concomitant
Figure 3 Altered retinal angiogenesis in DLK1-null mice. (A) Confocal images of retinas from wild-type or DLK1-null p5 and p14 pups stained for
isolectin B4. Retinas of null mice p5 show a hyperfused plexus compared with wild-type. Right panel depicts the quantification of retinal areas covered
by vessels. Bars represent mean+ SEM from 10 mice (*P, 0.05). (B) Isolectin B4 immunofluorescence showing increased tip cell and filopodia in the
DLK1-null p5 pups angiogenic front. Squared areas are blown-up in the right panels. Bar graph depicts the quantitative analysis of tip cells and filopodia
(*P, 0.05). Scale bars: A: 200; B: 50 (left side) and 20 (right side) mm.
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expression of human DLK1 (Figure 4J). In a model of zebrafish xeno-
graft tumour formation,25 suppression of DLK1 resulted in a clearly
visible migration of vessels towards the tumour cell mass, an effect
reversed by co-injection with human DLK1 mRNA (Figure 5A–C ).
Our results suggest that DLK1 plays a role in the developing vascula-
ture of zebrafish, hence supporting that this protein contributes to
setting the general angiogenic programme.
3.5 DLK1 inhibits angiogenesis by
antagonizing the NOTCH pathway
To study the potential interaction of DLK1 with the NOTCH signalling
pathway in the context of angiogenesis, we used several approaches.
First, we found that expression of theNOTCH-dependent luciferase re-
porter Hes-1 was reduced in a dose-dependent manner, in endothelial
cells expressing DLK1 (Figure 6A). This occurred at levels similar to
the effect observed after treatment with the g-secretase inhibitor
DAPT (Figure 6B).We then studied the abundance of NOTCH signalling
pathway-related proteins in MLEC from Dlk1-null mice and observed
that the levels of the Notch1 intracellular domain (NICD) indicative of
Notch1 activation and the downstream transcriptional effector Hey1
were markedly augmented (Figure 6C), thus suggesting that the
absence of Dlk1 might contribute to derepress the Notch pathway. As
Notch receptors have been shown to regulate Snail family of proteins
in specific types of endothelial cells,26,27 we examinedwhether their ex-
pression was altered in endothelial cells from Dlk1-null mice.We found
increased levels of Snail mRNA and Slug protein in MLEC of Dlk1-null
mice, compared with MLEC from wild-type mice (Figure 6D), suggesting
that Dlk1 is inhibiting the expression of Snail and Slug.
Figure 4 DLK1 affects angiogenesis in WT zebrafish embryos. (A–F ) Tg(Fli:eGFP); Tg(gata1:dsRed) embryos at 72 h post-fertilization. (G– I )
Tg(fli:eGFP) at day 6 post-fertilization. (A, B, D, and E) Bright-field images. (C and F) Fluorescent microscope images. General morphology of wild-type
embryos (A) and intersegmental artery sprouts and GATA-dsRED-labelled erythrocytes (B and C) from a wild-type embryo injected with 500 pg of
control cDNA plasmid. (D–F) Embryos injected with 500 pg of DLK1 cDNA. In (C) and (F), arrows highlight intersegmental arteries. (G) Embryo
injected with 250 mM control MO oligonucleotide (MO control). (H ) Ectopic sprouts of the SIV in a DLK1-morphant embryo. (I ) Phenotype
after co-injection of DLK1 MO (MO Dlk1) and DLK1 cDNA. (J ) Quantification of ectopic angiogenesis in day 6 pf larvae injected with control
MO, DLK1 MO alone, or co-injected with human DLK1 plasmid (hDLK1). Arrows identify SIV. Each experiment, which included 100–300
embryos, was repeated at least twice. Bars represent mean+ SEM (*′P, 0.05 vs. control; *P, 0.025 vs. control; #P, 0.025 vs. MO 250 mM).
Scale bars: A and D: 2 mm; B, C and E– I: 200 mm.
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3.6 DLK1 inhibits angiogenesis upstream
of NOTCH intracellular signalling
To evaluate the step at which DLK1 was interfering with the NOTCH
signalling pathway, we performed studies of angiotube formation in
PAEC in resting conditions and in PAEC overexpressing NICD,
which are engineered to express active NOTCH-dependent signals
in a ligand–receptor independent manner. In keeping with previous
reports,27 PAEC stably expressing NICD showed high levels of Hes-1-
dependent luciferase expression (data not shown). Expression of
DLK1 resulted in the expected inhibition of angiotube formation,
both in the presence and absence of VEGF (see Supplementary ma-
terial online, Figure S5, upper panels). In contrast, angiotube formation
in cells with constitutive NICD expression was not reduced by DLK1
(see Supplementary material online, Figure S5, lower panels), thus sug-
gesting that DLK1 acts at the level of NOTCH receptors to regulate
angiogenesis. To confirm that DLK1 was also inhibiting NOTCH sig-
nalling in another model, we performed a series of studies in zebrafish
embryos expressing the NOTCH-dependent fluorescent effector
RbpJk. As shown in Supplementary material online, Figure S6A and
B, DAPT drastically reduced fluorescence associated with NOTCH
signalling, while antagonism of DLK1 with an MO moderately
enhanced it (see Supplementary material online, Figure S6C). In con-
trast, injection of embryos with the human Dlk1 mRNA promoted
a marked abrogation of NOTCH-dependent fluorescence (see Sup-
plementary material online, Figure S6D). Taken together, these
results support the notion that DLK1 is negatively regulating
NOTCH signalling, likely by interfering with canonical ligand–recep-
tor interaction.
4. Discussion
Since the initial description of DLK1 as an inhibitor of adipocyte and
neuroendocrine differentiation, a growing body of evidence suggests
that it may act as a general inhibitor of differentiation, including cell
types of non-neuroendocrine lineage such as osteoblasts,28 myo-
cytes,29 haematopoietic cells,30 and chondrocytes.31 Work by one
of our groups has established that DLK1 may antagonize the
NOTCH pathway in several settings and that this antagonism relies
on its capacity to act as a non-canonical ligand.4 Precisely, because
an essential role of the NOTCH pathway is to regulate angiogenesis,
we asked what role, if any, could be played by DLK1 in the context of
this fundamental biological process. This work shows for the first time
to our knowledge that DLK1 is: (i) expressed in adult endothelial cells
and (ii) it acts as a powerful antiangiogenic factor in several models
and organisms. Furthermore, we have been able to provide evidence
supporting that this inhibition of angiogenesis is mediated by interfer-
ence with the NOTCH pathway and plausibly with canonical ligand–
receptor interaction.
Several reports lend a basis for the interaction between DLK1 and
the NOTCH 1 receptor, suggesting that the former exerts an antag-
onistic role due to its capacity to bind to those NOTCH EGF-like
repeats also involved in the interaction with NOTCH ligands.4,7,8
Figure 5 Knockdown of DLK1 promotes, and DLK1 inhibits, tumour-induced angiogenesis in zebrafish xenograft assay. Fluorescent microscopic
images of (A) 4 dpf control and (B) MO-injected larvae xenografted with MDA-MB-435 tumour cells at 2 dpf. Arrows highlight SIV and arrowheads
identify tumour cells. (C ) Quantification of embryos showing tumour-induced angiogenesis when injected with MO against DLK1 at different concen-
trations or co-injected with human Dlk1 capped mRNA. Each condition, which included 25–50 embryos, was repeated at least twice. Bars represent
mean+ SEM (*P, 0.025 vs. control; #P, 0.025 vs. MO 250 mM). Scale bars: 200 mm.
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However, other authors have proposed alternative modes of action
for DLK1 invoking direct interaction with fibronectin32 and other
molecules, such as IGFBP1,6 although these interactions do not
involve the DLK1 EGF-like region. It has been established that three
of the five canonical NOTCH ligands (Jagged 1, Dll1, and Dll4) are
expressed in endothelial cells and play critical roles in vascular angio-
genesis.12 For example, maintenance of arterial identity relies on the
Notch1–Dll interaction.33,34 Heterozygous deletion of Dll4 in mice
or pharmacological inhibition of NOTCH signalling was associated
with increased numbers of filopodia-extending endothelial tip cells
and increased expression of tip cell marker genes compared with con-
trols,35 thus suggesting that Dll4 is a negative regulator of vascular
sprouting. Dll4 and Jagged1 have opposing effects on sprouting angio-
genesis mediated by VEGF signalling, by controlling the equilibrium
between tip and stalk cells through a mechanism regulated by the gly-
cosyltransferase Fringe, which post-translationally modifies the
NOTCH receptors.33 In zebrafish, the absence of NOTCH promotes
a shift towards the tip cell phenotype, favouring vessel sprouting, and
loss of Dll4 was associated with an increased endothelial cell
number.36 In addition, several studies have found that the NOTCH
pathway is generally related to angiogenesis inhibition, at least when
the canonical ligand Dll4 is involved (see Phng and Gerhardt37 for
review). The interaction between canonical and non-canonical
NOTCH ligands is a complex one38 and further studies are needed
to establish the precise interplay of DLK1 with the canonical
NOTCH ligands in the vasculature. The phenotype found in the
retinas of Dlk1-null mice (increased number of vessels, tip cells, and
filopodia in selective areas) is consistent with the antiangiogenic
action of DLK1 observed in cultured cells and in the zebrafish
model. Our data clearly show that Dlk1 interferes with Notch signal-
ling but do not define the precise level of interaction or the Notch
canonical ligand potentially affected. Thus, a straightforward interpret-
ation of discrepancies between the vascular phenotype observed in
this study in mice and zebrafish and those previously reported in
models bearing genetic modifications of NOTCH canonical ligands
is still premature.
Figure 6 DLK1 inhibits angiogenesis by antagonizing the NOTCH signalling pathway. (A) Quantification of NOTCH signalling in bovine endothelial
cells measured by Hes-1 activity. (B) cDNA DLK1 (0.25 mg) decreases Hes-1 activity to a similar extent than 0.5 mM of the g-secretase inhibitor,
DAPT. Bars represent mean+ SEM of three independent experiments assayed per triplicate (*P, 0.05). Lysates from control cells or cells trans-
fected with a control vector or with DLK1-HA (50 mg) were incubated with DLK1, HA, and actin antibodies. Densitometric analysis yielded a
2.5-fold increased DLK1 protein with respect to controls. (C) Representative western blots (n ¼ 3) from Notch intracellular domain (NICD,
upper panel) and Hey1 (lower panel) showing protein up-regulation in lung endothelial cells from KO mice. Quantification of four different
mouse preparations per group by densitometry and qRT-PCR (mean+ SEM; *P, 0.05). (D) Representative western blot of Slug protein (n ¼ 3).
Quantitative qRT-PCR and densitometric analysis showing Slug and Snail are enhanced in DLK1 KO mice (n ¼ 4, mean+ SEM; *P, 0.05).
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Antagonism of the NOTCH pathway by the use of decoys has
proven to be effective in animal models of tumour progression39
and the use of endogenous inhibitors of the NOTCH pathway has
been claimed to represent a potential therapeutic avenue.40 The regu-
lation of angiogenesis in tumours is the object of intense study in the
context of providing effective means of deferring or suppressing
human tumoral growth. However, tumours seem to find mechanisms
of escape from anti-VEGF-directed therapies,41 and hence, it is essen-
tial to search for new candidates and targets mediating an antiangio-
genic effect. In this pathological setting, and supported by our
observations in zebrafish tumour-induced angiogenesis, it will be
worth determining the potential of DLK1 to abrogate tumour-
dependent angiogenesis in mammals.
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Supplementary material is available at Cardiovascular Research online.
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